AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26346590 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 148
Study 24269033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (HF.A00232) plus levocetirizine
Number of subjects: 60
Study 24269033 — intervention group
Group type: COMPARATOR
Intervention: Levocetirizine plus placebo
Number of subjects: 60
Study 22702508 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH527123, 30 mg daily PO
Number of subjects: 34
Study 22702508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 20465448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's block with ropivacaine 0.2%
Number of subjects: 79
Study 20465448 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sub‐Tenon's block)
Number of subjects: 79
Study 18753472 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rt‐PA)
Number of subjects: 624
Study 18753472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study 15735456 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid test with standard counseling
Number of subjects: 761
Study 15735456 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid test with standard counseling
Number of subjects: 761
Study 15735456 — intervention group
Group type: COMPARATOR
Intervention: Traditional test with standard counseling
Number of subjects: 761
Study 15735456 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional test with choice of written pretest materials or standard counseling
Number of subjects: 761
Study 12088977 — intervention group
Group type: COMPARATOR
Intervention: Air group
Number of subjects: 24
Study 12088977 — intervention group
Group type: EXPERIMENTAL
Intervention: N67 group
Number of subjects: 24
Study 12088977 — intervention group
Group type: EXPERIMENTAL
Intervention: N40 group
Number of subjects: 24
Study 12088977 — intervention group
Group type: EXPERIMENTAL
Intervention: N40-c group
Number of subjects: 24
Study 9546566 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl or bupivacaine
Number of subjects: 100
Study 7844300 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory and visual messages classified as 'control enhancement'
Number of subjects: 42
Study 3294284 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dextro‐amphetamine
Number of subjects: 30
Study 3294284 — intervention group
Group type: COMPARATOR
Intervention: Pimozide
Number of subjects: 30
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BMI (bottom three deciles, <23.5 kg/m2)
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (top two deciles, >30.7 kg/m2)
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-genetic and MR within-sibling analyses
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-linear MR
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: MR Egger
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-genetic within-sibling analysis
Number of subjects: 378244
Study 31800047 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 378244
Study 29569470 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced program (HOME), involving pre/post discharge visits and two follow-up phone calls
Number of subjects: 400
Study 29569470 — intervention group
Group type: COMPARATOR
Intervention: In-hospital consultation using the home and community environment assessment and the Lawton Instrumental Activities of Daily Living assessment
Number of subjects: 400
Study 28050914 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected recovery
Number of subjects: 11
Study 28050914 — intervention group
Group type: COMPARATOR
Intervention: Standardized recovery
Number of subjects: 11
Study 26030762 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 194
Study 26030762 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic-focused psychodynamic psychotherapy
Number of subjects: 194
Study 26030762 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation training
Number of subjects: 194
Study 26030762 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonassertive cluster
Number of subjects: 194
Study 26030762 — intervention group
Group type: COMPARATOR
Intervention: Normative cohort
Number of subjects: 194
Study 26030762 — intervention group
Group type: COMPARATOR
Intervention: Cohort of patients with major depression
Number of subjects: 194
Study 23924878 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary inserted between 16 and 20 weeks' gestation
Number of subjects: 808
Study 23924878 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pessary)
Number of subjects: 808
Study 20356395 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga classes (12 weekly sessions)
Number of subjects: 210
Study 20356395 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapeutic exercise classes (12 weekly sessions)
Number of subjects: 210
Study 20356395 — intervention group
Group type: COMPARATOR
Intervention: Self-care book
Number of subjects: 210
Study 18344733 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (mean dose 11.3 mg)
Number of subjects: 122
Study 18344733 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (mean dose 3.0 mg)
Number of subjects: 122
Study 16546280 — intervention group
Group type: EXPERIMENTAL
Intervention: IH636 grape seed proanthocyanidin extract (GSPE) 100 mg three times a day orally for 6 months
Number of subjects: 66
Study 16546280 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 6 months
Number of subjects: 66
Study 16546280 — intervention group
Group type: EXPERIMENTAL
Intervention: IH636 grape seed proanthocyanidin extract (GSPE)
Number of subjects: 66
Study 16546280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 14530912 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg every 28 days for 2 years)
Number of subjects: 1640
Study 14530912 — intervention group
Group type: COMPARATOR
Intervention: CMF (six 28-day cycles)
Number of subjects: 1640
Study 10714421 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (rehabilitation program consisting of exercise and education twice a week for 8 weeks)
Number of subjects: 38
Study 10714421 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (conventional community care)
Number of subjects: 38
Study 9325508 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 50
Study 9325508 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy (Control)
Number of subjects: 50
Study 8330466 — intervention group
Group type: EXPERIMENTAL
Intervention: CGS-12970 (100, 200, 300, or 400 mg twice a day)
Number of subjects: 20
Study 8330466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3521860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 40
Study 3521860 — intervention group
Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 40
Study 29764419 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate
Number of subjects: 197
Study 29764419 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine
Number of subjects: 197
Study 27418249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent occlusion therapy (IO therapy) using liquid crystal glasses (Amblyz), 4 hours per day, set at 30‐second opaque/transparent intervals (occluded 50% of wear time)
Number of subjects: 34
Study 27418249 — intervention group
Group type: COMPARATOR
Intervention: Continuous occlusion therapy using traditional adhesive patches, 2 hours per day (occluded 100% of wear time)
Number of subjects: 34
Study 24566987 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation over the unaffected limb with mirror visual feedback (experimental condition)
Number of subjects: 14
Study 24566987 — intervention group
Group type: COMPARATOR
Intervention: Stimulation over the affected limb with mirror visual feedback
Number of subjects: 14
Study 24566987 — intervention group
Group type: COMPARATOR
Intervention: Stimulation over the unaffected limb without mirror visual feedback
Number of subjects: 14
Study 24566987 — intervention group
Group type: COMPARATOR
Intervention: Stimulation over the affected limb without mirror visual feedback
Number of subjects: 14
Study 22130394 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of stretching activities
Number of subjects: 52
Study 22130394 — intervention group
Group type: COMPARATOR
Intervention: 30 minutes of quiet sitting (nonstretched)
Number of subjects: 52
Study 20021624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic index meal
Number of subjects: 15
Study 20021624 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic index meal
Number of subjects: 15
Study 18972248 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged static stretching (SS) for 10 min, with each leg stretched unilaterally for 40 s with eight different exercises, repeated three times
Number of subjects: 10
Study 18972248 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged static stretching (SS)
Number of subjects: 10
Study 15930204 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antibiotics (ABX; amoxicillin plus symptom medication)
Number of subjects: 223
Study 15930204 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (WW; symptom medication only)
Number of subjects: 223
Study 15930204 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antibiotics (ABX)
Number of subjects: 223
Study 15930204 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (WW)
Number of subjects: 223
Study 15385223 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (200 mg daily)
Number of subjects: 26
Study 15385223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 10227568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (50 mg t.d.s. for the first 2 weeks, then 100 mg t.d.s. for the subsequent weeks)
Number of subjects: 121
Study 10227568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 10227568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 121
Study 9056156 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomeprol (new nonionic contrast medium)
Number of subjects: 0
Study 9056156 — intervention group
Group type: COMPARATOR
Intervention: Low osmolar nonionic contrast media
Number of subjects: 0
Study 1859010 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 15 micrograms/kg
Number of subjects: 12
Study 1859010 — intervention group
Group type: COMPARATOR
Intervention: Oral solution of fentanyl citrate (control) 15 micrograms/kg
Number of subjects: 12
Study 1859010 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 12
Study 1859010 — intervention group
Group type: COMPARATOR
Intervention: Oral solution of fentanyl citrate (control)
Number of subjects: 12
Study 7341285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg
Number of subjects: 6
Study 7341285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg tid for 3 days
Number of subjects: 6
Study 7341285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin pre-treatment
Number of subjects: 6
Study 7341285 — intervention group
Group type: COMPARATOR
Intervention: Clonidine 300 micrograms
Number of subjects: 6
Study 7341285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin alone
Number of subjects: 6
Study 31851067 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless Automated Hearing‐Test System
Number of subjects: 120
Study 31851067 — intervention group
Group type: COMPARATOR
Intervention: Automated Testing
Number of subjects: 120
Study 31851067 — intervention group
Group type: COMPARATOR
Intervention: Manual Testing
Number of subjects: 120
Study 31851067 — intervention group
Group type: COMPARATOR
Intervention: Two-step Protocol (automated followed by manual testing)
Number of subjects: 120
Study 31851067 — intervention group
Group type: COMPARATOR
Intervention: Conventional Audiometry
Number of subjects: 120
Study 30137473 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-Process Bereavement Group Intervention - Chinese (DPBGI-C)
Number of subjects: 125
Study 30137473 — intervention group
Group type: COMPARATOR
Intervention: Loss-Oriented Bereavement Group Intervention - Chinese (LOBGI-C)
Number of subjects: 125
Study 28865493 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 3 mg/kg from weeks 0 to 6, then 3, 6, or 10 mg/kg every 8 weeks from weeks 14 to 46
Number of subjects: 0
Study 28865493 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 3 mg/kg
Number of subjects: 0
Study 28865493 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 0
Study 26650562 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 60
Study 26650562 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 60
Study 25111437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryolipolysis treatment on larger thigh
Number of subjects: 11
Study 25111437 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral thigh)
Number of subjects: 11
Study 25111437 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient surveys
Number of subjects: 11
Study 25111437 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical photographs
Number of subjects: 11
Study 21212911 — intervention group
Group type: EXPERIMENTAL
Intervention: Third generation OCP (150 microgram desogestrel + 30 microgram ethinylestradiol)
Number of subjects: 100
Study 21212911 — intervention group
Group type: COMPARATOR
Intervention: Second generation OCP (150 microgram levonorgestrel + 30 microgram ethinylestradiol)
Number of subjects: 100
Study 18082782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 50
Study 18082782 — intervention group
Group type: COMPARATOR
Intervention: Ice cube
Number of subjects: 50
Study 17173586 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching module utilized during consultation in group A (50 patients)
Number of subjects: 100
Study 17173586 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients in group A who underwent treatment
Number of subjects: 100
Study 17173586 — intervention group
Group type: COMPARATOR
Intervention: Control group B (50 patients)
Number of subjects: 100
Study 12942727 — intervention group
Group type: EXPERIMENTAL
Intervention: Serebryany klyuch mineral water (group 2)
Number of subjects: 27
Study 12942727 — intervention group
Group type: COMPARATOR
Intervention: Tap water (group 1)
Number of subjects: 27
Study 10715982 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfix plug-and-patch
Number of subjects: 141
Study 8813098 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 0
Study 1571851 — intervention group
Group type: EXPERIMENTAL
Intervention: sCT (200 IU every other day)
Number of subjects: 21
Study 1571851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 2995279 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g dietary fibre supplements in the form of a corn‐based biscuit (Group A)
Number of subjects: 40
Study 2995279 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g dietary fibre supplements as wheat bran (Group B)
Number of subjects: 40
Study 2995279 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 40
Study 31752260 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exercise (45 min of one-arm cranking and 8 h walking/day) during caloric restriction (3.2 kcal/kg body weight day)
Number of subjects: 0
Study 31752260 — intervention group
Group type: COMPARATOR
Intervention: Control diet and restricted exercise
Number of subjects: 0
Study 28699542 — intervention group
Group type: EXPERIMENTAL
Intervention: Pesticide-free community mobilisation
Number of subjects: 0
Study 28699542 — intervention group
Group type: COMPARATOR
Intervention: Conventional dengue controls
Number of subjects: 0
Study 25151254 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic endoscopic coagulation (PEC)
Number of subjects: 347
Study 25151254 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (Control)
Number of subjects: 347
Study 23511486 — intervention group
Group type: EXPERIMENTAL
Intervention: News story about a mass shooting
Number of subjects: 1797
Study 23511486 — intervention group
Group type: EXPERIMENTAL
Intervention: News story about a mass shooting with gun restriction proposal
Number of subjects: 1797
Study 23511486 — intervention group
Group type: EXPERIMENTAL
Intervention: News story about a mass shooting with large-capacity magazine ban proposal
Number of subjects: 1797
Study 23511486 — intervention group
Group type: COMPARATOR
Intervention: No exposure (control group)
Number of subjects: 1797
Study 21357805 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lifestyle counseling by nurse practitioners (NPs) using a standardized software program
Number of subjects: 457
Study 21357805 — intervention group
Group type: COMPARATOR
Intervention: Usual care by general practitioners (GP‐UC)
Number of subjects: 457
Study 19673651 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell culture-derived influenza vaccine (CCIV)
Number of subjects: 2654
Study 19673651 — intervention group
Group type: COMPARATOR
Intervention: Conventional egg-based vaccine
Number of subjects: 2654
Study 16378672 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic defibrillation (n=33)
Number of subjects: 74
Study 16378672 — intervention group
Group type: COMPARATOR
Intervention: Monophasic defibrillation (n=25)
Number of subjects: 74
Study 12752139 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept therapy
Number of subjects: 229
Study 12752139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 11128739 — intervention group
Group type: EXPERIMENTAL
Intervention: New pattern of electrical stimulation
Number of subjects: 27
Study 11128739 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27
Study 9350389 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release lithium carbonate, 800 mg/day
Number of subjects: 27
Study 9350389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 1332985 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate and oestradiol valerate (PC/EV) administered until the twelfth week of gestation
Number of subjects: 120
Study 1332985 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study 3715407 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 50 to 3900 mg daily for 1 week
Number of subjects: 0
Study 3715407 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 100 mg daily for 1 week
Number of subjects: 0
Study 3715407 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) higher doses (above 100 mg)
Number of subjects: 0
Study 29460337 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking Sense intervention (3 one-to-one individualized sessions)
Number of subjects: 52
Study 29460337 — intervention group
Group type: COMPARATOR
Intervention: Control discussion (knowledge-only)
Number of subjects: 52
Study 28531423 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥25% sodium reduction (n=21 patients)
Number of subjects: 38
Study 28531423 — intervention group
Group type: COMPARATOR
Intervention: <25% sodium reduction (n=14 patients)
Number of subjects: 38
Study 28531423 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥25% sodium reduction
Number of subjects: 38
Study 28531423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 24908265 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 transection plus 'Energy‐boosting and Yin‐nourishing anti‐perspirant formula' (Group A)
Number of subjects: 300
Study 24908265 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 transection (Group B)
Number of subjects: 300
Study 24908265 — intervention group
Group type: COMPARATOR
Intervention: T2 transection (Group C, control group)
Number of subjects: 300
Study 24908265 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 300
Study 22300013 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training (cognitive activities with gait and balance exercises)
Number of subjects: 17
Study 22300013 — intervention group
Group type: COMPARATOR
Intervention: Single-task training (gait and balance activities without cognitive tasks)
Number of subjects: 17
Study 22300013 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training
Number of subjects: 17
Study 22300013 — intervention group
Group type: COMPARATOR
Intervention: Single-task training
Number of subjects: 17
Study 20375125 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue: Take Control (FTC) program
Number of subjects: 30
Study 20375125 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (WL) group
Number of subjects: 30
Study 19043355 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional programme combining safe postural shifts and the backward‐chaining method (Group I)
Number of subjects: 120
Study 19043355 — intervention group
Group type: COMPARATOR
Intervention: Conventional training to rise unassisted after a fall (Group II - control)
Number of subjects: 120
Study 16540864 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched treatment (manipulation, stabilization exercise, or specific exercise)
Number of subjects: 123
Study 16540864 — intervention group
Group type: COMPARATOR
Intervention: Unmatched treatment (manipulation, stabilization exercise, or specific exercise)
Number of subjects: 123
Study 12669236 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and prolonged oral etoposide (group 1; n=58)
Number of subjects: 285
Study 12669236 — intervention group
Group type: COMPARATOR
Intervention: Etoposide alone (group 2; n=59)
Number of subjects: 285
Study 12669236 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and prolonged oral etoposide (group 1; n=84)
Number of subjects: 285